Skip to main content

BeOne Medicines Ltd.

BEIGF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001651308

In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesONC

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by BeOne Medicines Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
14 filings
6 insiders, $309.4M in total
Insiders trading
6
Net value
−$309.4M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for BeOne Medicines Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for BeOne Medicines Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Baker JulianDirector8,099,179IndirectSep 16, 20263
Baker FelixDirector8,099,179IndirectSep 16, 20263
Baker Bros. Advisors LPDirector8,099,179IndirectSep 16, 20263
Baker Brothers Life Sciences LPDirector8,099,179IndirectSep 16, 20263
667, L.P.Director8,099,179IndirectSep 16, 20263
Baker Bros. Advisors (GP) LLCDirector8,099,179IndirectSep 16, 20263
Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd0Sep 10, 20263
Ball Titus B.Principal Accounting Officer0Sep 3, 20263
Wu XiaobinPresident and COO0Aug 27, 20268
Lee Chan HenrySVP, General Counsel0Aug 13, 202616
Oyler JohnChief Executive Officer0Aug 12, 202613
Rosenberg AaronChief Financial Officer0Aug 5, 20263
Wang LaiPresident, Global Head of R&D0Jun 25, 20266
Hooper Anthony CDirector83,720Jun 15, 20261
Sharp ShaliniDirector38,116Jun 15, 20261
Brandicourt OlivierDirector46,306Jun 15, 20261
Riva AlessandroDirector73,164Jun 15, 20262
Dugan MargaretDirector73,164Jun 15, 20262
Sawyers Charles LazelleDirector18,984Jun 15, 20261
Mooney Elizabeth FisherDirector18,980Jun 15, 20261
Yi QingqingDirector0Jun 3, 20261
Sanders Corazon (Corsee) D.Director0May 27, 20262
Hillhouse Investment Management, Ltd.10% Owner125,045,741IndirectDec 4, 20240
HHLR Advisors, Ltd.10% Owner125,045,741IndirectDec 4, 20240
Wang Julia AijunChief Financial Officer0Jul 3, 20240
Glazer Donald W.Director2,718,464Jun 7, 20240
Malley ThomasDirector46,696Jun 20, 20230
Huang JaneCMO, Hematology0Dec 16, 20210
Amgen Inc10% Owner18,943,802Sep 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2021 (view filing)Jul 1Same dayWang Julia AijunChief Financial OfficerSSaleAmerican Depositary Shares−308$349.06−$107.5K−100.0%0 after
Jul 1, 2021 (view filing)Jul 1Same dayWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−4.85K$348.16−$1.69M−100.0%0 after6 lots
Jul 8, 2021 (view filing)Jul 62 daysWu XiaobinPresident, COO & GM ChinaSSaleAmerican Depositary Shares−10.2K$325.53−$3.31M−100.0%0 after8 lots
Jul 8, 2021 (view filing)Jul 6-72 daysOyler JohnChief Executive OfficerSSale−85.0K$25.29−$2.15M−1.3%6.34M after2 lots
Jul 8, 2021 (view filing)Jul 6-72 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−38.8K$318.52−$12.4M−99.2%300 after23 lots
Jul 8, 2021 (view filing)Jul 8Same dayOyler JohnChief Executive OfficerSSale−51.3K$24.24−$1.24M−0.8%6.09M after
Jul 8, 2021 (view filing)Jul 7-81 dayOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−16.2K$318.62−$5.16M−100.0%0 after15 lots
Jul 19, 2021 (view filing)Jul 154 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−21.0K$332.42−$6.98M−100.0%0 after6 lots
Jul 22, 2021 (view filing)Jul 20-212 daysOyler JohnChief Executive OfficerSSale−39.6K$24.60−$974.2K−0.7%5.64M after2 lots
Jul 22, 2021 (view filing)Jul 20-212 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−31.3K$313.70−$9.80M−100.0%0 after15 lots
Jul 22, 2021 (view filing)Jul 22Same dayOyler JohnChief Executive OfficerSSale−57.9K$23.71−$1.37M−1.1%5.43M after
Jul 22, 2021 (view filing)Jul 22Same dayOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−11.3K$317.98−$3.60M−100.0%0 after12 lots
Aug 5, 2021 (view filing)Aug 32 daysOyler JohnChief Executive OfficerSSale−41.4K$25.17−$1.04M−0.8%4.85M after
Aug 5, 2021 (view filing)Aug 32 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−42.0K$337.48−$14.2M−100.0%0 after18 lots
Aug 5, 2021 (view filing)Aug 4-51 dayOyler JohnChief Executive OfficerSSale−83.2K$25.97−$2.16M−1.9%4.22M after2 lots
Aug 5, 2021 (view filing)Aug 4-51 dayOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−42.1K$342.51−$14.4M−100.0%0 after22 lots
Sep 2, 2021 (view filing)Sep 1-21 dayHuang JaneCMO, HematologySSaleAmerican Depositary Shares−1.09K$318.88−$346.6K−100.0%0 after2 lots
Sep 2, 2021 (view filing)Aug 31-Sep 12 daysOyler JohnChief Executive OfficerSSale−204.4K$24.09−$4.92M−6.5%2.92M after3 lots
Sep 2, 2021 (view filing)Aug 31-Sep 22 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−84.3K$317.54−$26.8M−100.0%0 after22 lots
Sep 13, 2021 (view filing)Sep 103 daysAmgen Inc10% OwnerPPurchaseAmerican Depositary Shares+165.5K$302.06+$50.0M+0.9%18.9M after
Sep 15, 2021 (view filing)Sep 132 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−12.9K$358.14−$4.62M−100.0%0 after8 lots
Sep 16, 2021 (view filing)Sep 14-152 daysOyler JohnChief Executive OfficerSSale−347.8K$28.82−$10.0M−16.7%1.74M after2 lots
Sep 16, 2021 (view filing)Sep 14-152 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−64.0K$371.14−$23.8M−100.0%0 after17 lots
Sep 22, 2021 (view filing)Sep 202 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−6.00K$397.96−$2.39M−100.0%0 after14 lots
Oct 21, 2021 (view filing)Oct 192 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−1.50K$372.78−$559.2K−100.0%0 after7 lots
Nov 10, 2021 (view filing)Nov 8-92 daysWu XiaobinPresident, COO & GM ChinaSSaleAmerican Depositary Shares−10.0K$358.27−$3.58M−100.0%0 after22 lots
Nov 10, 2021 (view filing)Nov 82 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−4.50K$349.81−$1.57M−100.0%0 after13 lots
Nov 10, 2021 (view filing)Nov 82 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−4.50K$350.04−$1.58M−100.0%0 after14 lots
Nov 19, 2021 (view filing)Nov 172 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−1.50K$381.34−$572.0K−100.0%0 after9 lots
Dec 2, 2021 (view filing)Dec 11 dayHuang JaneCMO, HematologySSaleAmerican Depositary Shares−1.05K$359.86−$377.5K−100.0%0 after2 lots
Dec 16, 2021 (view filing)Dec 142 daysHuang JaneCMO, HematologySSaleAmerican Depositary Shares−1.50K$278.14−$417.2K−100.0%0 after6 lots
May 6, 2022 (view filing)May 51 dayWu XiaobinPresident, COO & GM ChinaSSaleAmerican Depositary Shares−6.72K$164.35−$1.11M−100.0%0 after7 lots
Jun 8, 2022 (view filing)Jun 62 daysWu XiaobinPresident, COO & GM ChinaSSaleAmerican Depositary Shares−3.41K$141.99−$484.2K−100.0%0 after
Jun 8, 2022 (view filing)Jun 62 daysWang LaiGlobal Head of R&DSSaleAmerican Depositary Shares−660$142.00−$93.7K−100.0%0 after
Jun 21, 2022 (view filing)Jun 174 daysWang Julia AijunChief Financial OfficerSSaleAmerican Depositary Shares−161$136.64−$22.0K−100.0%0 after
Jun 22, 2022 (view filing)Jun 17-215 daysWu XiaobinPresident, COO & GM ChinaSSaleAmerican Depositary Shares−1.59K$142.63−$226.5K−100.0%0 after2 lots
Jun 22, 2022 (view filing)Jun 17-215 daysWang LaiGlobal Head of R&DSSaleAmerican Depositary Shares−1.17K$145.35−$169.8K−100.0%0 after2 lots
Jun 28, 2022 (view filing)Jun 271 dayWang LaiGlobal Head of R&DSSaleAmerican Depositary Shares−458$177.32−$81.2K−100.0%0 after
Jul 18, 2022 (view filing)Jul 117 daysWang Julia AijunChief Financial OfficerSSaleAmerican Depositary Shares−317$158.50−$50.2K−100.0%0 afterAmended
Aug 9, 2022 (view filing)Aug 54 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−5.00K$193.85−$969.3K−100.0%0 after10 lots
Aug 9, 2022 (view filing)Aug 5-84 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−11.1K$197.91−$2.19M−100.0%0 after15 lots
Sep 22, 2022 (view filing)Sep 20-212 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−50.0K$152.13−$7.61M−100.0%0 after18 lots
Nov 17, 2022 (view filing)Nov 152 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−25.0K$206.84−$5.17M−100.0%0 after7 lots
Nov 17, 2022 (view filing)Nov 152 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−4.93K$206.82−$1.02M−100.0%0 after6 lots
Nov 17, 2022 (view filing)Nov 152 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−1.99K$210.14−$417.5K−100.0%0 after
Dec 15, 2022 (view filing)Dec 132 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−3.01K$211.32−$636.7K−100.0%0 after3 lots
Dec 29, 2022 (view filing)Dec 27-292 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−3.20K$224.43−$718.9K−100.0%0 after4 lots
Dec 29, 2022 (view filing)Dec 27-292 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−6.41K$224.43−$1.44M−100.0%0 after8 lots
Jan 11, 2023 (view filing)Jan 9-112 daysWang XiaodongDirector, Other: Chair, Scientific Advisory BrdSSaleAmerican Depositary Shares−5.00K$251.36−$1.26M−100.0%0 after6 lots
Jan 12, 2023 (view filing)Jan 102 daysOyler JohnChief Executive OfficerSSaleAmerican Depositary Shares−6.80K$248.52−$1.69M−100.0%0 after5 lots